EC approves teduglutide for short bowel syndrome

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) and Takeda Pharmaceutical Co. Ltd (Tokyo:4502) said the European Commission approved Revestive teduglutide to treat short bowel syndrome (SBS). Takeda, which has...